On the basis of various in vitro findings the relations of the magnitudes of inhibition of antiplatelet effect dependant on CYP2C19 for different PPIs is the following: omeprazole = esomeprazole > pantoprazole > lansoprazole > rabeprazole 41.
Con base en los diferentes hallazgos in vitro, la magnitud de la inhibición del efecto antiplaquetario dependiente de CYP2C19 para los diferentes IBP es la siguiente: omeprazol = esomeprazol > pantorazol > lansoprazol > rabeprazol 41.